Related Experiment Videos

Menorrhagia and 3-keto-desogestrel-copper medicated intrauterine device

¹Department of Gynecology and Obstetrics, University of Utrecht, Netherlands.

European Journal of Obstetrics, Gynecology, and Reproductive Biology

|December 28, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare.

Clinical rheumatology·2019

A retrospective analysis of medication prescription records for determining the levels of compliance and persistence to urate-lowering therapy for the treatment of gout and hyperuricemia in The Netherlands.

Clinical rheumatology·2018

The effect of low-dose 3-keto-desogestrel added to a copper-releasing intrauterine contraceptive device on menstrual blood loss: a double-blind, dose-finding, placebo-controlled study.

American journal of obstetrics and gynecology·2000

Reconsidering menorrhagia in gynecological practice. Is a 30-year-old definition still valid?

European journal of obstetrics, gynecology, and reproductive biology·1998

Menorrhagia--a search for epidemiological risk markers.

Maturitas·1997

A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss.

Obstetrics and gynecology·1995

See all related articles